Evaluation of bioactive glass and demineralized freeze dried bone allograft in the treatment of periodontal intraosseous defects: A comparative clinico-radiographic study

Aim: The purpose of this study was to evaluate the efficacy of demineralized freeze dried bone allograft (DFDBA) and bioactive glass by clinically and radiographically in periodontal intrabony defects for a period of 12 months. Materials and Methods: Ten systemically healthy patients diagnosed with...

Full description

Bibliographic Details
Main Authors: Kishore Kumar Katuri, P Jaya Kumar, Chakrapani Swarna, D Narasimha Swamy, Kurumathur V Arun
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Journal of Indian Society of Periodontology
Subjects:
Online Access:http://www.jisponline.com/article.asp?issn=0972-124X;year=2013;volume=17;issue=3;spage=367;epage=372;aulast=Katuri
id doaj-1aac5a8d94394016bc156e8c79cae61e
record_format Article
spelling doaj-1aac5a8d94394016bc156e8c79cae61e2020-11-24T23:26:25ZengWolters Kluwer Medknow PublicationsJournal of Indian Society of Periodontology0972-124X2013-01-0117336737210.4103/0972-124X.115660Evaluation of bioactive glass and demineralized freeze dried bone allograft in the treatment of periodontal intraosseous defects: A comparative clinico-radiographic studyKishore Kumar KaturiP Jaya KumarChakrapani SwarnaD Narasimha SwamyKurumathur V ArunAim: The purpose of this study was to evaluate the efficacy of demineralized freeze dried bone allograft (DFDBA) and bioactive glass by clinically and radiographically in periodontal intrabony defects for a period of 12 months. Materials and Methods: Ten systemically healthy patients diagnosed with chronic periodontitis, with radiographic evidence of at least a pair of contralateral vertical osseous defects were included in this study. Defect on one-side is treated with DFDBA and the other side with bioactive glass. Clinical and radiographic measurements were made at baseline 6 month and 12 month after the surgery. Results: Compared to baseline, the 12 month results indicated that both treatment modalities resulted in significant changes in all clinical parameters (gingival index, probing depth, clinical attachment level (CAL) and radiographic parameters (bone fill); P < 0.001FNx01). However, sites treated with DFDBA exhibited statistically significantly more changes compared to the bioactive glass in probing depth reduction (2.5 ± 0.1 mm vs. 1.8 ± 0.1 mm) CAL gain 2.4 ± 0.1 mm versus 1.7 ± 0.2 mm; ( P < 0.001FNx01). At 12 months, sites treated with bioactive glass exhibited 56.99% bone fill and 64.76% bone fill for DFDBA sites, which is statistically significant ( P < 0.05FNx01). Conclusion: After 12 months, there was a significant difference between the two materials with sites grafted with DFDBA showing better reduction in probing pocket depth, gain in CAL and a greater percentage of bone fill when compared to that of bioactive glass.http://www.jisponline.com/article.asp?issn=0972-124X;year=2013;volume=17;issue=3;spage=367;epage=372;aulast=KaturiBioactive glassdemineralized freeze dried bone allograftintrabony defectosteoconductionosteoinduction
collection DOAJ
language English
format Article
sources DOAJ
author Kishore Kumar Katuri
P Jaya Kumar
Chakrapani Swarna
D Narasimha Swamy
Kurumathur V Arun
spellingShingle Kishore Kumar Katuri
P Jaya Kumar
Chakrapani Swarna
D Narasimha Swamy
Kurumathur V Arun
Evaluation of bioactive glass and demineralized freeze dried bone allograft in the treatment of periodontal intraosseous defects: A comparative clinico-radiographic study
Journal of Indian Society of Periodontology
Bioactive glass
demineralized freeze dried bone allograft
intrabony defect
osteoconduction
osteoinduction
author_facet Kishore Kumar Katuri
P Jaya Kumar
Chakrapani Swarna
D Narasimha Swamy
Kurumathur V Arun
author_sort Kishore Kumar Katuri
title Evaluation of bioactive glass and demineralized freeze dried bone allograft in the treatment of periodontal intraosseous defects: A comparative clinico-radiographic study
title_short Evaluation of bioactive glass and demineralized freeze dried bone allograft in the treatment of periodontal intraosseous defects: A comparative clinico-radiographic study
title_full Evaluation of bioactive glass and demineralized freeze dried bone allograft in the treatment of periodontal intraosseous defects: A comparative clinico-radiographic study
title_fullStr Evaluation of bioactive glass and demineralized freeze dried bone allograft in the treatment of periodontal intraosseous defects: A comparative clinico-radiographic study
title_full_unstemmed Evaluation of bioactive glass and demineralized freeze dried bone allograft in the treatment of periodontal intraosseous defects: A comparative clinico-radiographic study
title_sort evaluation of bioactive glass and demineralized freeze dried bone allograft in the treatment of periodontal intraosseous defects: a comparative clinico-radiographic study
publisher Wolters Kluwer Medknow Publications
series Journal of Indian Society of Periodontology
issn 0972-124X
publishDate 2013-01-01
description Aim: The purpose of this study was to evaluate the efficacy of demineralized freeze dried bone allograft (DFDBA) and bioactive glass by clinically and radiographically in periodontal intrabony defects for a period of 12 months. Materials and Methods: Ten systemically healthy patients diagnosed with chronic periodontitis, with radiographic evidence of at least a pair of contralateral vertical osseous defects were included in this study. Defect on one-side is treated with DFDBA and the other side with bioactive glass. Clinical and radiographic measurements were made at baseline 6 month and 12 month after the surgery. Results: Compared to baseline, the 12 month results indicated that both treatment modalities resulted in significant changes in all clinical parameters (gingival index, probing depth, clinical attachment level (CAL) and radiographic parameters (bone fill); P < 0.001FNx01). However, sites treated with DFDBA exhibited statistically significantly more changes compared to the bioactive glass in probing depth reduction (2.5 ± 0.1 mm vs. 1.8 ± 0.1 mm) CAL gain 2.4 ± 0.1 mm versus 1.7 ± 0.2 mm; ( P < 0.001FNx01). At 12 months, sites treated with bioactive glass exhibited 56.99% bone fill and 64.76% bone fill for DFDBA sites, which is statistically significant ( P < 0.05FNx01). Conclusion: After 12 months, there was a significant difference between the two materials with sites grafted with DFDBA showing better reduction in probing pocket depth, gain in CAL and a greater percentage of bone fill when compared to that of bioactive glass.
topic Bioactive glass
demineralized freeze dried bone allograft
intrabony defect
osteoconduction
osteoinduction
url http://www.jisponline.com/article.asp?issn=0972-124X;year=2013;volume=17;issue=3;spage=367;epage=372;aulast=Katuri
work_keys_str_mv AT kishorekumarkaturi evaluationofbioactiveglassanddemineralizedfreezedriedboneallograftinthetreatmentofperiodontalintraosseousdefectsacomparativeclinicoradiographicstudy
AT pjayakumar evaluationofbioactiveglassanddemineralizedfreezedriedboneallograftinthetreatmentofperiodontalintraosseousdefectsacomparativeclinicoradiographicstudy
AT chakrapaniswarna evaluationofbioactiveglassanddemineralizedfreezedriedboneallograftinthetreatmentofperiodontalintraosseousdefectsacomparativeclinicoradiographicstudy
AT dnarasimhaswamy evaluationofbioactiveglassanddemineralizedfreezedriedboneallograftinthetreatmentofperiodontalintraosseousdefectsacomparativeclinicoradiographicstudy
AT kurumathurvarun evaluationofbioactiveglassanddemineralizedfreezedriedboneallograftinthetreatmentofperiodontalintraosseousdefectsacomparativeclinicoradiographicstudy
_version_ 1725555217575968768